For now, at least two lawmakers Tommy Tuberville (R-Ala.) and Diana Harshbarger (R-Tenn.) have issued letters asking the FDA to limit enforcement action against certain peptides, including BPC-157
Strategies to minimize reactions include rotating injection sites consistently to avoid repeated trauma to the same area, ensuring the solution is at room temperature before injection (cold injections can increase irritation), injecting slowly rather than quickly, and using a smaller gauge needle for less tissue trauma
QD community oral or SC MOTS-c Daily SC, often 5 days on / 2 off AOD-9604 Daily SC Attribute Max studied dose SLU-PP-332 50 mg/kg BID (mouse, 28 days) MOTS-c 5-15 mg/kg (mouse) AOD-9604 1-5 mg/day in human Phase 2 Attribute Peak efficacy signal SLU-PP-332 ~25-30% fat-mass reduction in DIO mice over 28 days MOTS-c Improved insulin sensitivity in aged mice AOD-9604 Modest fat-loss signal in human Phase 2
[1] It often forms nodules, and can be associated with fibrosis and adhesions
This concentration works well for those wanting to dose in 100mcg increments, such as 300mcg (0.15ml) or 400mcg (0.2ml)